Monthly Archives February 2018

Medsafe Alert Communication 15 February 2018 Medsafe has published a new alert communication Arthrem - potential risk of harm to the liver - statement under section 98 of the Medicines Act 1981 Read the alert communication at: www.medsafe.govt.nz/safety/EWS/2018/Arthrem.asp Click here for the Arthrem Pharmacy Announcement Click here for Arthrem Q&A      

New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from  1 April 2018. (pending Medsafe approval which was given 22 February 2018) Aripiprazole Sandoz Tab 10 mg  30                  Pharmacode TBA                 Schedule price $17.50 Aripiprazole Sandoz Tab 15 mg  30                  Pharmacode TBA                 Schedule price $17.50 Aripiprazole Sandoz Tab 20 mg  30                  Pharmacode TBA                 Schedule…

Click here to access the GO healthy New Zealand product return form. All returns will be handled direct with GOhealthy. Please DO NOT return stock for credit to ProPharma / PWR under any circumstances. This is as stated a precautionary recall and you MUST act on this immediately. We thank you in anticipation of your ongoing support.

As advised via Pharmac Tender announcement there is to be a change in the listing and future sole supply. New listing from 1 March 2018 HML only. Pip Taz Sandoz Inj 4 g with tazobactam 0.5 g 10 vials.                          Pharmacode  2539187                     Schedule price $38.00 Incumbent brand(s) Piperacillin with tazobactam  Inj 4 g with tazobactam 0.5 g, vial,…

Following on from an RFP dated 12 May 2017. PHARMAC are now proposing to list and fund Pregabalin in both the Pharmaceutical Schedule Section B and Section H (HML) from  1 May 2018 . *   Note: Pfizer has Medsafe approval for pregabalin 25 mg, 75 mg, 150 mg and 300 mg capsules under the brand name Lyrica since 24 November…

As we are all aware there is to be a change in supplier and Community Sole Supply for the above mentioned product from 1 May 2018. As we have always said – “we will provide best overall service and returns to pharmacy” - we have worked with the supplier to clear existing stock prior to transitioning to the new brand.…

Nutricia have advised that they are releasing a new pack size (857 gm) which will be listed and fully funded in the Pharmaceutical Schedule from 1 March 2018. Product will not be released to the market until all the existing 350 gm stock is exhausted. Click here to read Nutricia notification. Click here to read product data sheet. Due to…

Please note the following changes for 1 March 2018. Bosvate Tab 2.5 mg , 5 mg an 10 mg 90 will be added to STAT DISPENSING list. Simvastatin Tab 10 mg , 20 mg, 40 mg and 80 mg both Arrow and Mylan will have STAT DISPENSING reinstated. Please note that we are supplying the Arrow brand at either the…

From 1 February 2018, paediatric oral/enteral feed (Infatrini) 1 kcal/ml, 125 ml OP will be listed and funded subject to Special Authority criteria for infants with faltering growth who are fluid restricted or volume intolerant. Patients must be under 18 months of age or weigh less than 8 kg. Product is now available for supply. Pharmacode 2537923

12
Close